About: Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe Coronavirus disease 2019: A case report

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe Coronavirus disease 2019: A case report Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 15 May 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) bài báo khoa học (vi) article scientifique publié en 2020 (fr) artículu científicu espublizáu en mayu de 2020 (ast) artykuł naukowy opublikowany 15 maja 2020 (pl) scientific article published on 15 May 2020 (en) наукова стаття, опублікована 15 травня 2020 (uk)
publication date	wds:Q95297091-82AE2D58-36DA-4FC7-A28B-CB22596BEC41
publication date	2020-05-15 00:00:00Z (xsd:dateTime)
cites work	wds:Q95297091-0B448E13-7176-4C64-B7A6-6950424AE9D6 wds:Q95297091-373F6BC1-D816-452F-84AA-F4D309F16606 wds:Q95297091-39446CA3-2237-4BF7-957B-E0C132927DBF wds:Q95297091-40EB8186-7792-49DD-8B5A-117C0CEAD780 wds:Q95297091-4BBEF94C-77C7-43F1-B6C9-3BC24484D365 wds:Q95297091-50629EC5-DFB5-4A6B-BE98-5DBCC0C532C3 wds:Q95297091-6F686512-9058-4C09-A703-7EBB3908C64E wds:Q95297091-732CDD83-FBBA-4B6A-A7BC-B227711282F0 wds:Q95297091-8439E4D9-92AB-4143-BA5B-6ADA4E46ABCA wds:Q95297091-9E0DF3AC-9ADA-4D09-BC1D-6073224BE480 wds:Q95297091-A5088551-BC18-404B-A8F1-273E8CBDD492 wds:Q95297091-A5C36C4F-4DCD-4178-991C-0CA7B28CCE9C wds:Q95297091-C40CB686-61F4-41CA-8FAC-A98F31BDA59D wds:Q95297091-C47980CC-12AB-4A80-B476-A5E324DC7628 wds:Q95297091-CC8E2B19-17AA-403B-A0C4-35D4FDF0374C wds:Q95297091-CD0D1269-1D53-4C38-8E14-D0BB43E59A1C wds:Q95297091-CFCBB1C1-AA11-4E02-8CBC-E6EAB609C006 wds:Q95297091-DE71A555-1B42-4ACB-8FE3-1AB2F6C3E99B wds:Q95297091-F351896B-CC7B-41B3-93B2-CEFDCC25BCB1
cites work	Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure Tocilizumab treatment in COVID-19: A single center experience How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1 Coronavirus Disease 2019 (COVID-19) in Italy Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies Compassionate Use of Remdesivir for Patients with Severe Covid-19 Persistent viral RNA positivity during recovery period of a patient with SARS-CoV-2 infection Safety profile of anakinra in the management of rheumatologic, metabolic and autoinflammatory disorders High-density lipoprotein (HDL) particle size and concentration changes in septic shock patients.
author name string	wds:Q95297091-061ADFD1-9B3E-46D1-A3F0-74EA7A90BC09 wds:Q95297091-0B9C2666-7F27-47D0-8C96-EFA718FCC3C2 wds:Q95297091-0E7AE3D1-0E11-4860-AADB-42BEE90C60A1 wds:Q95297091-2730992E-E641-4CE8-9C6D-C5D3E060C31E wds:Q95297091-52E0DF1E-3553-4B5B-ADB5-B2905B7A778D wds:Q95297091-6835990F-D01B-4C0C-9372-66B8708036D0 wds:Q95297091-80F37791-FCEA-41E4-84FC-671973660A78 wds:Q95297091-9EF30A59-ECE5-4445-8E31-37C610AA8D73 wds:Q95297091-A194EBF2-4A6F-4403-80D3-F5A0F4AC6B5B wds:Q95297091-CED0DCAC-4A27-4FB5-A957-6C92AFFD1CB8 wds:Q95297091-DD86A56F-C893-4ED5-8FFB-210BFC53E091
author name string	Marco Franzetti Alessandro Pandolfo Enrico Iemoli Stefania Piconi Paolo Faccioli Manuela Carugati Ugo Pozzetti Chiara Molteni Ernesto Longoni Gioacchino Castaldo Valentina Ormas
rdfs:label	Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe Coronavirus disease 2019: A case report (en) Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe Coronavirus disease 2019: A case report (nl)
skos:prefLabel	Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe Coronavirus disease 2019: A case report (en) Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe Coronavirus disease 2019: A case report (nl)
name	Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe Coronavirus disease 2019: A case report (en) Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe Coronavirus disease 2019: A case report (nl)
title	wds:Q95297091-5273E6D8-C6C0-4695-B5E3-950DB6B73F88
title	Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe Coronavirus disease 2019: A case report (en)
instance of	wds:Q95297091-24846864-2a92-46ce-bb84-0b45410ffbe4 wds:Q95297091-E9329CAF-2CFB-40C2-BC9F-5CB7F2AB8AB6
instance of	scholarly article case report
main subject	wds:Q95297091-030DCE0D-5BD7-4C28-9AB5-9E2199B287EF wds:Q95297091-A8C8FCA1-2F7A-4DF3-8DA8-CF0F2213FC76
main subject	anakinra remdesivir
PubMed ID	wds:Q95297091-0F489C7D-AACB-4E68-98EC-7630B049D535
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32422376
PubMed ID	32422376
published in	wds:Q95297091-4127639B-06DB-4CF1-BAE5-4F02DAB0E447
published in	International Journal of Infectious Diseases
DOI	wds:Q95297091-32AF24A4-6239-4560-95FC-F2FB2692872B
DOI	http://dx.doi.org/10.1016/J.IJID.2020.05.050
DOI	10.1016/J.IJID.2020.05.050
Semantic Scholar corpus ID	wds:Q95297091-9542039A-C583-4B82-BFF7-5449132C3B81
Semantic Scholar corpus ID	218643885
Dimensions Publication ID	wds:Q95297091-1DC6C57A-0D39-4DBB-9205-9AC122A38C85
Dimensions Publication ID	1127636406
PMCID	wds:Q95297091-D8DDDF11-7BB8-4502-8217-BAFBE83E31E4
PMCID	7228890

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software